| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9311635 | Urology | 2005 | 5 Pages |
Abstract
Despite the ongoing controversy surrounding its effectiveness in the treatment of metastatic renal cell carcinoma, the results of our preliminary study suggest that interleukin-2, interferon-alpha, 5-fluorouracil combination immunochemotherapy may be effective as adjuvant therapy after complete resection of pT3N0M0 renal cell carcinoma.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Sung Kyu Hong, Cheol Kwak, Sang Eun Lee,